Case number 1:23-cv-00161
Shionogi & Co., Ltd. et al v. Norwich Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 1, 2025 | 117 | STIPULATION TO EXTEND TIME For Proposed Pretrial Order Exchanges to July 15, 2025 - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 07/01/2025) (2) |
| Jun 23, 2025 | 115 | STIPULATION TO EXTEND TIME - Expert Discovery Deadlines to (see Stipulation) - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 06/23/2025) (2) |
| Jun 23, 2025 | 116 | SO ORDERED re 115 STIPULATION TO EXTEND TIME - Expert Discovery Deadlines (Set/Reset Scheduling Order Deadlines: Expert Discovery due by 7/9/2025). SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 6/23/2025. (dlw) (Entered: 06/23/2025) (2) |
| Jun 6, 2025 | 114 | STIPULATION TO EXTEND TIME regarding various Expert Discovery Deadlines to (see Stipulation) - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 06/06/2025) (2) |
| May 22, 2025 | 113 | NOTICE of Withdrawal of Counsel by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. (Jacobs, Karen) (Entered: 05/22/2025) (3) |
| Apr 30, 2025 | 112 | NOTICE of Change of Address for Lisa B. Pensabene, Hassen A. Sayeed, Hailey S. Verano, and Jing Ying (Amy) Zhao by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. (Clark, Cameron) (Entered: 04/30/2025) (4) |
| Apr 21, 2025 | 110 | SO ORDERED re 108 Stipulation and Order Regarding Protective Order. Signed by Judge Maryellen Noreika on 4/21/2025. (dlw) (Entered: 04/21/2025) (2) |
| Apr 21, 2025 | 111 | SO ORDERED re 109 STIPULATION TO EXTEND Case Deadlines (Set/Reset Scheduling Order Deadlines: Expert Discovery due by 6/11/2025. Daubert Motions due by 6/16/2025. Answering Brief due 6/25/2025. Reply Brief due 6/30/2025). Signed by Judge Maryellen Noreika on 4/21/2025. (dlw) (Entered: 04/21/2025) (2) |
| Apr 18, 2025 | 109 | STIPULATION TO EXTEND TIME for certain deadlines in the Scheduling Order (D.I. 18) to dates as outlined in stipulation - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Jacobs, Karen) (Entered: 04/18/2025) (2) |
| Apr 7, 2025 | 108 | STIPULATION and [Proposed] Order Regarding Protective Order by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 04/07/2025) (2) |
| Mar 31, 2025 | 107 | NOTICE OF SERVICE of 1. Reply Expert Report of Mark D. Hollingsworth, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 10,759,814, 11,306,106, and 11,261,198 2. Reply Expert Report of Richard A. Martinello, M.D. Regarding the Invalidity of U.S. Patent Nos. 10,633,397 and 11,306,106 3. Reply Expert Report of Seth Cohen, Ph.D. 4. Reply Expert Report of Thomas R. Webb, Ph.D. filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Keller, Karen) (Entered: 03/31/2025) (2) |
| Mar 28, 2025 | 106 | NOTICE OF SERVICE of 1) Reply Expert Report of Allan Myerson, Ph.D. Regarding Norwich Pharmaceuticals, Inc.'s and Alvogen PB Research & Development LLC's Infringement of U.S. Patent No. 11,261,198 and 2) Corrected Responsive Expert Report of Sean T. Liu, M.D., Ph.D., Regarding the Validity of the '397 Patent and the '106 Patent filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Jacobs, Karen) (Entered: 03/28/2025) (4) |
| Feb 24, 2025 | 104 | NOTICE OF SERVICE of Rebuttal Expert Report of Michael J. Zaworotko, Ph.D. regarding Noninfringement of U.S. Patent No. 11,261,198 filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Keller, Karen) (Entered: 02/24/2025) (2) |
| Feb 24, 2025 | 105 | NOTICE OF SERVICE of 1) Responsive Expert Report of Leonard J. Chyall, PH.D., Regarding the Validity of the '814 Patent, the '106 Patent, and the '198 Patent, 2) Responsive Expert Report Of Reza Oliyai, Ph.D., Regarding The Validity Of The '406 Patent, The '397 Patent, The '814 Patent, And The '106 Patent, 3) Responsive Expert Report of Jeffrey D. Winkler, Ph.D., Regarding the Validity of the '835 Patent, the '441 Patent, the '406 Patent, the '106 Patent, the '814 Patent, the '198 Patent, and the '397 Patent and 4) Responsive Expert Report of Sean T. Liu, M.D., Ph.D., Regarding the Validity of the '397 Patent and the '106 Patent filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 02/24/2025) (5) |
| Feb 5, 2025 | 102 | STIPULATION to Extend Case Deadlines by Shionogi & Co., Ltd., Hoffmann-La Roche Inc., Genentech, Inc.. (Clark, Cameron) (Entered: 02/05/2025) (2) |
| Feb 5, 2025 | 103 | SO ORDERED re 102 Stipulation to Extend Case Deadlines (Set/Reset Scheduling Order Deadlines: Rebuttal Expert Reports due by 2/21/2025. Reply Expert Reports due by 3/28/2025. Expert Discovery due by 5/7/2025. Daubert Motions due by 5/21/2025). Signed by Judge Maryellen Noreika on 2/5/2025. (dlw) (Entered: 02/05/2025) (2) |
| Jan 31, 2025 | 101 | NOTICE requesting Clerk to remove Carolyn S. Wall as co-counsel. Reason for request: No longer with firm. (Clark, Cameron) (Entered: 01/31/2025) (4) |
| Jan 6, 2025 | 100 | NOTICE of Change of Address of Ross E. Blau by Norwich Pharmaceuticals, Inc., Alvogen PB Research & Development LLC (DiBenedetto, Emily) (Entered: 01/06/2025) (2) |
| Dec 9, 2024 | 98 | MOTION for Pro Hac Vice Appearance of Attorney Jason Murata - filed by Norwich Pharmaceuticals, Inc., Alvogen PB Research & Development LLC. (DiBenedetto, Emily) (Entered: 12/09/2024) (4) |
| Dec 9, 2024 | 99 | Pro Hac Vice Fee - Credit Card Payment received for Jason Murata. ( re 98 MOTION for Pro Hac Vice Appearance of Attorney Jason Murata )( Payment of $ 50, receipt number ADEDC-4565368).(DiBenedetto, Emily) (Entered: 12/09/2024) (0) |
| Nov 18, 2024 | 96 | NOTICE OF SERVICE of 1.) Opening Expert Report of Mark D. Hollingsworth, Ph.D. Regarding the Invalidity of U.S. Patent Nos. 10,759,814, 11,306,106, and 11,261,198 2.) Opening Expert Report of Richard A. Martinello, M.D. Regarding the Invalidity of U.S. Patent Nos. 10,633,397 and 11,306,106 3.) Opening Expert Report of Seth Cohen, Ph.D. 4.) Opening Expert Report of Thomas Webb, Ph.D. filed by Norwich Pharmaceuticals, Inc., Alvogen PB Research & Development LLC.(Hoeschen, Nathan) (Entered: 11/18/2024) (2) |
| Nov 18, 2024 | 97 | NOTICE OF SERVICE of Opening Expert Report of Allan Myerson, Ph.D filed by Shionogi & Co., Ltd., Hoffmann-La Roche Inc., Genentech, Inc..(Clark, Cameron) (Entered: 11/18/2024) (3) |
| Oct 25, 2024 | 95 | STIPULATION TO EXTEND TIME Regarding Various Expert Deadlines to (See Stipulation) - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 10/25/2024) (2) |
| Oct 15, 2024 | 94 | ORDER ADOPTING 89 REPORT AND RECOMMENDATION - IT IS HEREBY ORDERED that the September 23, 2024 Report and Recommendation is ADOPTED. Defendants' motion for leave to amend is DENIED without prejudice. Signed by Judge Maryellen Noreika on 10/15/2024. (dlw) (Entered: 10/15/2024) (1) |
| Oct 9, 2024 | 92 | MOTION for Pro Hac Vice Appearance of Attorney Hailey S. Verano - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 10/09/2024) (4) |
| Oct 9, 2024 | 93 | Pro Hac Vice Fee - Credit Card Payment received for Hailey S. Verano. ( re 92 MOTION for Pro Hac Vice Appearance of Attorney Hailey S. Verano )( Payment of $ 50, receipt number ADEDC-4519529).(Clark, Cameron) (Entered: 10/09/2024) (0) |
| Sep 26, 2024 | 91 | REDACTED VERSION of 87 Letter, by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (DiBenedetto, Emily) (Entered: 09/26/2024) (30) |
| Sep 23, 2024 | 89 | REPORT AND RECOMMENDATIONS- re 85 MOTION for Teleconference to Resolve Discovery Dispute. IT IS ORDERED that the teleconference set in this matter for September 24, 2024 at 3:00 p.m. is CANCELLED. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than four (4) pages) and the Response to the Objections (no longer than four (4) pages). No further briefing shall be permitted with respect to objections without leave of the Court.( Objections to R&R due by 10/7/2024) Signed by Judge Sherry R. Fallon on 9/23/2024.This order has been emailed to local counsel. (lih) Modified on 10/8/2024 (lih). (Entered: 09/23/2024) (13) |
| Sep 23, 2024 | 90 | STIPULATION TO EXTEND TIME to file a public version of D.I. 87 to September 26, 2024 - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (DiBenedetto, Emily) (Entered: 09/23/2024) (2) |
| Sep 17, 2024 | 88 | Letter to The Honorable Sherry R. Fallon from Karen Jacobs regarding 87 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Jacobs, Karen) Modified on 9/17/2024 (lih). (Entered: 09/17/2024) (0) |
| Sep 16, 2024 | 87 | [SEALED] Letter to The Honorable Sherry R. Fallon from Karen E. Keller regarding Amendment of Defendants' Answer and Counterclaims. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8)(Keller, Karen) Modified on 9/16/2024 (lih). (Entered: 09/16/2024) (0) |
| Jul 25, 2024 | 86 | SO ORDERED- re 85 MOTION for Teleconference to Resolve Discovery Dispute. A Discovery Dispute Motion Hearing is set for 9/24/2024 at 03:00 PM before Judge Sherry R. Fallon. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. The defendants should obtain court reporting services for the conference, with the cost to be shared equally between both sides. No later than 9/23/2024 at 11:00 a.m., the parties shall send a joint email to Larisha_Hicks@ded.uscourts.gov containing (i) the name of the court reporter; (ii) the name of the court reporting agency; and (iii) confirmation that the court reporter has been provided with the court's AT&T dial-in information. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Set Deadlines: (Moving submission due by no later than 11:00 a.m. on 9/16/2024, Responsive submission due by no later than 11:00 a.m. on 9/17/2024). Signed by Judge Sherry R. Fallon on. Signed by Judge Sherry R. Fallon on 7/25/2024. (lih) (Entered: 07/25/2024) (0) |
| Jul 24, 2024 | 85 | MOTION for Teleconference to Resolve Discovery Dispute - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 07/24/2024) (3) |
| Jul 19, 2024 | 84 | ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for Defendants' anticipated Motion to Amend, IT IS HEREBY ORDERED that this anticipated motion is referred to Magistrate Judge Fallon. The parties are directed to file Magistrate Judge Fallon's "Motion for Teleconference to Resolve [Protective Order or Discovery] Dispute" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon, forms. ORDERED by Judge Maryellen Noreika on 7/19/2024. (dlw) (Entered: 07/19/2024) (0) |
| Jul 17, 2024 | 83 | STIPULATION TO EXTEND TIME to amend or supplement the pleadings to July 18, 2024 - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Keller, Karen) (Entered: 07/17/2024) (2) |
| Jul 16, 2024 | 80 | NOTICE requesting Clerk to remove Chad A. Landmon as co-counsel.. (Keller, Karen) (Entered: 07/16/2024) (1) |
| Jul 16, 2024 | 81 | MOTION for Pro Hac Vice Appearance of Attorney Edward M. Mathias and Ross E. Blau - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Keller, Karen) (Entered: 07/16/2024) (5) |
| Jul 16, 2024 | 82 | Pro Hac Vice Fee - Credit Card Payment received for Edward M. Mathias and Ross E. Blau. ( re 81 MOTION for Pro Hac Vice Appearance of Attorney Edward M. Mathias and Ross E. Blau )( Payment of $ 100, receipt number ADEDC-4452384).(Keller, Karen) (Entered: 07/16/2024) (0) |
| May 21, 2024 | 79 | NOTICE OF SERVICE of Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc.'s Supplemental Responses to Defendants' First Set of Requests for Admission (Nos. 1-28) filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 05/21/2024) (3) |
| May 1, 2024 | 78 | SO ORDERED re 77 Stipulation and Order (regarding infringement). Signed by Judge Maryellen Noreika on 5/1/2024. (dlw) (Entered: 05/01/2024) (4) |
| Apr 30, 2024 | 77 | STIPULATION -- Stipulation and [Proposed] Order Regarding Infringement -- by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 04/30/2024) (4) |
| Mar 28, 2024 | 76 | NOTICE OF SERVICE of Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc.'s Objections and Responses to Defendants' Second Set of Interrogatories (No. 11) - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 03/28/2024) (3) |
| Mar 22, 2024 | 75 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(DiBenedetto, Emily) (Entered: 03/22/2024) (2) |
| Mar 21, 2024 | 73 | SO ORDERED re 72 Authenticity and Business Records Stipulation and Order. Signed by Judge Maryellen Noreika on 3/21/2024. (dlw) (Entered: 03/21/2024) (2) |
| Mar 21, 2024 | 74 | Letter to The Honorable Maryellen Noreika from Karen Jacobs regarding -- Joint Letter Regarding Markman Hearing. (Jacobs, Karen) (Entered: 03/21/2024) (1) |
| Mar 20, 2024 | 72 | STIPULATION -- Authenticity and Business Records Stipulation and [Proposed] Order -- by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 03/20/2024) (2) |
| Mar 14, 2024 | 71 | NOTICE OF SERVICE of (1) Plaintiffs' Final Validity Contentions; and (2) Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc.'s Supplemental Objections and Responses to Defendants' Interrogatories (Nos. 1 and 4) filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 03/14/2024) (3) |
| Mar 13, 2024 | 70 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 03/13/2024) (4) |
| Mar 8, 2024 | 69 | NOTICE OF SERVICE of Shionogi & Co., Ltd., Hoffman-La Roche Inc., and Genentech, Inc.'s Responses to Defendants' First Set of Requests for Admission (Nos. 1-28) filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 03/08/2024) (3) |
| Feb 27, 2024 | 68 | NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc., and Alvogen PB Research & Development LLC's Second Set of Interrogatories to Plaintiffs (No. 11) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 02/27/2024) (2) |
| Feb 21, 2024 | 67 | NOTICE to Take Deposition of Defendants Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC on date(s) mutually agreed upon by the parties filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 02/21/2024) (9) |
| Feb 16, 2024 | 63 | NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's Final Invalidity Contentions filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(DiBenedetto, Emily) (Entered: 02/16/2024) (2) |
| Feb 16, 2024 | 64 | NOTICE to Take Deposition of Kosuke Anan Pursuant to Federal Rule of Civil Procedure 30(b)(1) on March 26, 2024 filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 02/16/2024) (2) |
| Feb 16, 2024 | 65 | NOTICE to Take Deposition of Makoto Kawai Pursuant to Federal Rule of Civil Procedure 30(b)(1) on March 21, 2024 filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 02/16/2024) (2) |
| Feb 16, 2024 | 66 | NOTICE to Take Deposition of Plaintiffs Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on March 19, 2024 filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 02/16/2024) (15) |
| Feb 15, 2024 | 62 | NOTICE to Take Deposition of Jyoti Sachdeva, Raghav Gupta, and Shedly Jean-Lys on March 26th, March 27th and March 28th, 2024 filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 02/15/2024) (3) |
| Feb 12, 2024 | 61 | NOTICE OF SERVICE of Defendants' Second Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1 - 3) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(DiBenedetto, Emily) (Entered: 02/12/2024) (2) |
| Feb 7, 2024 | 60 | NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's First Set of Requests for Admission (Nos. 1-28) to Plaintiffs filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc. (Keller, Karen) Modified on 2/7/2024 (dlw). (Entered: 02/07/2024) (2) |
| Feb 1, 2024 | 59 | NOTICE OF SERVICE of 1) Plaintiffs' Final Infringement Contentions With Claim Charts; and 2) Plaintiffs' Election of Asserted Claims -- filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 02/01/2024) (3) |
| Jan 10, 2024 | 58 | NOTICE requesting Clerk to remove Alexander S. Krois as co-counsel.. (DiBenedetto, Emily) (Entered: 01/10/2024) (1) |
| Dec 28, 2023 | 57 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' Second Set of Requests for Admission filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(DiBenedetto, Emily) (Entered: 12/28/2023) (2) |
| Dec 18, 2023 | 56 | NOTICE OF SERVICE of Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc's Objections and First Supplemental Responses to Defendants' Interrogatories (Nos. 5-7) filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 12/18/2023) (3) |
| Nov 28, 2023 | 55 | NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for Admission (Nos. 9-13) to Norwich and Alvogen filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 11/28/2023) (3) |
| Nov 15, 2023 | 54 | NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1 - 3) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 11/15/2023) (2) |
| Nov 6, 2023 | 53 | NOTICE OF SERVICE of 1. Defendants' Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1 - 10) 2. Defendants' Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1 - 3) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Keller, Karen) (Entered: 11/06/2023) (2) |
| Nov 2, 2023 | 51 | ORAL ORDER: Plaintiffs' discovery motion (D.I. 41 ) is DENIED as stated at the November 1, 2023 teleconference. Ordered by Judge Jennifer L. Hall on 11/2/2023. (ceg) (Entered: 11/02/2023) (0) |
| Nov 2, 2023 | 52 | REDACTED VERSION of 48 Letter by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 11/02/2023) (5) |
| Oct 31, 2023 | 49 | MOTION for Pro Hac Vice Appearance of Attorney Amy Jing Ying Zhao - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 10/31/2023) (4) |
| Oct 31, 2023 | 50 | REDACTED VERSION of 45 Letter, by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 10/31/2023) (7) |
| Oct 27, 2023 | 48 | [SEALED] Letter to The Honorable Jennifer L. Hall from Nathan R. Hoeschen regarding Opposition Letter. (Hoeschen, Nathan) Modified on 10/27/2023 (ceg). (Entered: 10/27/2023) (0) |
| Oct 25, 2023 | 47 | NOTICE OF SERVICE of 1) Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc.'s Responses to Defendants First Set of Requests for Production (Nos. 1-53); and 2) Shionogi & Co., Ltd., Hoffmann-La Roche Inc., and Genentech, Inc.'s Objections and Responses to Defendants First Set of Interrogatories (Nos. 1-10) -- filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 10/25/2023) (3) |
| Oct 24, 2023 | 45 | [SEALED] Letter to The Honorable Jennifer L. Hall from Karen Jacobs regarding Disqualification of Defendants' Proposed Expert, Dr. Seth Cohen, and Protective Order. (Attachments: # 1 SEALED Ex. C)(Jacobs, Karen) Modified on 10/24/2023 (ceg). (Entered: 10/24/2023) (0) |
| Oct 24, 2023 | 46 | EXHIBIT re 45 Letter, by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. D, # 4 Ex. E)(Jacobs, Karen) (Entered: 10/24/2023) (0) |
| Oct 23, 2023 | 44 | NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1 - 38) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 10/23/2023) (2) |
| Oct 20, 2023 | 42 | NOTICE OF SERVICE of Plaintiffs' Amended Initial Infringement Contentions with Claim Charts -- filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 10/20/2023) (3) |
| Oct 20, 2023 | 43 | ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Protective Order Dispute (D.I. 41 ). A discovery dispute teleconference is scheduled for November 1, 2023 at 11:00 AM Eastern Time before Judge Jennifer L. Hall. By no later than October 24, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than October 27, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 10/20/2023. (ceg) (Entered: 10/20/2023) (0) |
| Oct 18, 2023 | 41 | MOTION for Teleconference to Resolve Protective Order Dispute - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. (Clark, Cameron) Modified on 10/18/2023 (ceg). (Entered: 10/18/2023) (3) |
| Oct 16, 2023 | 40 | ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for Plaintiffs' anticipated Motion to Disqualify an expert and related dispute regarding disclosure of Confidential or Highly Confidential Information to him, IT IS HEREBY ORDERED that this anticipated motion and related dispute are referred to Magistrate Judge Hall. The parties are directed to file Magistrate Judge Hall's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-jennifer-l-hall, forms. ORDERED by Judge Maryellen Noreika on 10/16/2023. (dlw) (Entered: 10/16/2023) (0) |
| Oct 10, 2023 | 39 | NOTICE requesting Clerk to remove Gabriella McIntyre as co-counsel.. (Keller, Karen) (Entered: 10/10/2023) (2) |
| Oct 6, 2023 | 38 | NOTICE OF SERVICE of 1) Plaintiffs' First Set of Requests for Admissions (Nos. 1-10) to Norwich and Alvogen and (2) Plaintiffs' First Set of Interrogatories (Nos. 1-3) to Norwich and Alvogen filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 10/06/2023) (3) |
| Sep 29, 2023 | 37 | NOTICE OF SERVICE of Defendants Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's Initial Invalidity Contentions filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 09/29/2023) (2) |
| Sep 25, 2023 | 36 | NOTICE OF SERVICE of 1. Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's First Set of Request for Production (Nos. 1 - 53) to Plaintiffs 2. Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's First Set of Interrogatories to Plaintiffs (Nos. 1 - 10) filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 09/25/2023) (2) |
| Sep 22, 2023 | 35 | NOTICE OF SERVICE of Plaintiffs' First Set of Requests (Nos. 1-38) to Norwich and Alvogen for the Production of Documents and Things -- filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Jacobs, Karen) (Entered: 09/22/2023) (3) |
| Aug 15, 2023 | 34 | MOTION for Pro Hac Vice Appearance of Attorney Gabriella M. McIntyre - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (DiBenedetto, Emily) (Entered: 08/15/2023) (4) |
| Aug 10, 2023 | 33 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions With Claim Charts filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 08/10/2023) (3) |
| Aug 2, 2023 | 32 | NOTICE requesting Clerk to remove Daniel B. OBoyle as co-counsel.. (Clark, Cameron) (Entered: 08/02/2023) (2) |
| Jun 26, 2023 | N/A | SO ORDERED re 31 STIPULATION TO EXTEND TIME for Defendants to produce samples of identified products to June 27, 2023. ORDERED by Judge Maryellen Noreika on 6/26/2023. (dlw) (Entered: 06/26/2023) (0) |
| Jun 23, 2023 | 31 | STIPULATION TO EXTEND TIME for Defendants to produce samples of identified products to June 27, 2023 - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (DiBenedetto, Emily) (Entered: 06/23/2023) (1) |
| Jun 12, 2023 | 30 | STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 6/12/2023. (dlw) (Entered: 06/12/2023) (30) |
| Jun 9, 2023 | 29 | PROPOSED ORDER -- [Proposed] Stipulated Protective Order -- by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 06/09/2023) (30) |
| Jun 6, 2023 | 28 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Pharma US, Inc. for Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc. filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Keller, Karen) (Entered: 06/06/2023) (2) |
| Jun 2, 2023 | N/A | SO ORDERED re 27 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to June 9, 2023. ORDERED by Judge Maryellen Noreika on 6/2/2023. (dlw) (Entered: 06/02/2023) (0) |
| Jun 1, 2023 | 27 | STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to June 9, 2023 - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 06/01/2023) (1) |
| May 31, 2023 | 26 | NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's First Amended Rule 26(a)(1) Initial Disclosures filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Keller, Karen) (Entered: 05/31/2023) (2) |
| May 30, 2023 | N/A | SO ORDERED re 25 STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to June 2, 2023. ORDERED by Judge Maryellen Noreika on 5/30/2023. (dlw) (Entered: 05/30/2023) (0) |
| May 26, 2023 | 25 | STIPULATION TO EXTEND TIME for the parties to file a Proposed Protective Order to June 2, 2023 - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 05/26/2023) (1) |
| May 25, 2023 | 24 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 05/25/2023) (3) |
| May 23, 2023 | 22 | NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(Keller, Karen) (Entered: 05/23/2023) (2) |
| May 23, 2023 | 23 | NOTICE OF SERVICE of Paragraph 3 Disclosures filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 05/23/2023) (3) |
| May 12, 2023 | 21 | Joint STIPULATION TO EXTEND TIME to file a Proposed Protective Order to May 26, 2023 - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 05/12/2023) (2) |
| May 12, 2023 | N/A | SO ORDERED re 21 Joint STIPULATION TO EXTEND TIME to file a Proposed Protective Order to May 26, 2023. ORDERED by Judge Maryellen Noreika on 5/12/2023. (dlw) (Entered: 05/12/2023) (0) |
| May 5, 2023 | 19 | NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 05/05/2023) (3) |
| May 5, 2023 | 20 | NOTICE OF SERVICE of Norwich Pharmaceuticals, Inc. and Alvogen PB Research & Development LLC's Rule 26(a)(1) Initial Disclosures filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc..(DiBenedetto, Emily) (Entered: 05/05/2023) (2) |
| Apr 12, 2023 | 16 | NOTICE of Appearance of Lisa B. Pensabene of O'Melveny & Myers LLP for Plaintiffs by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. (Clark, Cameron) (Entered: 04/12/2023) (2) |
| Apr 12, 2023 | 17 | MOTION for Pro Hac Vice Appearance of Attorney Hassen A. Sayeed, Daniel OBoyle, Carolyn S. Wall and Nancy L. Schroeder - filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd.. (Clark, Cameron) (Entered: 04/12/2023) (7) |
| Apr 12, 2023 | N/A | SO ORDERED re 17 MOTION for Pro Hac Vice Appearance of Attorney Hassen A. Sayeed, Daniel OBoyle, Carolyn S. Wall and Nancy L. Schroeder filed by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. ORDERED by Judge Maryellen Noreika on 4/12/2023. (dlw) (Entered: 04/12/2023) (0) |
| Apr 12, 2023 | 18 | SCHEDULING ORDER: Joinder of Parties due by 7/17/2024. Amended Pleadings due by 7/17/2024. Fact Discovery completed by 3/28/2024. Opening Expert Reports due by 10/25/2024. Rebuttal Expert Reports due by 12/19/2024. Reply Expert Reports due by 1/31/2025. Expert Discovery due by 4/3/2025. Daubert Motions due by 4/17/2025. Claim Construction Opening Brief served by 4/4/2024. Claim Construction Answering Brief served by 5/2/2024. Claim Construction Reply Brief served by 5/30/2024. Claim Construction Surreply Brief served by 6/27/2024. Joint Claim Construction Brief filed by 7/10/2024. A Markman Hearing is set for 8/8/2024 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 9/2/2025 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 9/8/2025 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/12/2023. (dlw) (Entered: 04/12/2023) (14) |
| Apr 10, 2023 | 15 | PROPOSED ORDER // Scheduling Order by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. (Attachments: # 1 Cover Letter to the Honorable Maryellen Noreika)(Jacobs, Karen) Modified on 4/11/2023 (dlw). (Entered: 04/10/2023) (Main Document) (14) |
| Apr 10, 2023 | 15 | PROPOSED ORDER // Scheduling Order by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. (Attachments: # 1 Cover Letter to the Honorable Maryellen Noreika)(Jacobs, Karen) Modified on 4/11/2023 (dlw). (Entered: 04/10/2023) (Cover Letter to the Honorable Maryellen Noreika) (1) |
| Mar 29, 2023 | 14 | ANSWER to 10 Answer to Complaint, Counterclaim - by Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd..(Clark, Cameron) (Entered: 03/29/2023) (30) |
| Mar 10, 2023 | N/A | CORRECTING ENTRY: The docket text of the 3/8/2023 Oral Order (D.I. 13) has been updated to reflect the correct year for the trial. The trial will begin on 9/8/2025. (dlw) (Entered: 03/10/2023) (0) |
| Mar 8, 2023 | 10 | ANSWER to 1 Complaint, COUNTERCLAIM against Genentech, Inc., Hoffmann-La Roche Inc., Shionogi & Co., Ltd. by Norwich Pharmaceuticals, Inc., Alvogen PB Research & Development LLC.(Hoeschen, Nathan) Modified on 3/8/2023 (dlw). (Entered: 03/08/2023) (30) |
| Mar 8, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alvogen Pharma US, Inc. for Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc. filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 03/08/2023) (2) |
| Mar 8, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Chad A. Landmon, Rebecca L. Clegg, Aaron Z. Savit and Alexander S. Krois - filed by Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 03/08/2023) (8) |
| Mar 8, 2023 | N/A | SO ORDERED re 12 MOTION for Pro Hac Vice Appearance of Attorney Matthew J. Becker, Chad A. Landmon, Rebecca L. Clegg, Aaron Z. Savit and Alexander S. Krois filed by Norwich Pharmaceuticals, Inc., Alvogen PB Research & Development LLC. ORDERED by Judge Maryellen Noreika on 3/8/2023. (dlw) (Entered: 03/08/2023) (0) |
| Mar 8, 2023 | 13 | ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The bench trial will be set to begin on 9/8/2025. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serves their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 3/8/2023. (dlw) Modified on 3/10/2023 (dlw). (Entered: 03/08/2023) (0) |
| Mar 8, 2023 | N/A | Pro Hac Vice Attorney Matthew J. Becker, Chad A. Landmon, Aaron Z. Savit, Rebecca L. Clegg, and Alexander S. Krois for Alvogen PB Research & Development LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/08/2023) (0) |
| Feb 15, 2023 | 8 | SUMMONS Returned Executed by Shionogi & Co., Ltd., Genentech, Inc., Hoffmann-La Roche Inc..Alvogen PB Research & Development LLC served on 2/15/2023, answer due 3/8/2023. (Jacobs, Karen) (Entered: 02/15/2023) (2) |
| Feb 15, 2023 | 9 | SUMMONS Returned Executed by Shionogi & Co., Ltd., Genentech, Inc., Hoffmann-La Roche Inc..Norwich Pharmaceuticals, Inc. served on 2/15/2023, answer due 3/8/2023. (Jacobs, Karen) (Entered: 02/15/2023) (2) |
| Feb 15, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 02/15/2023) (0) |
| Feb 13, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4066373.) - filed by Shionogi & Co., Ltd., Genentech, Inc., Hoffmann-La Roche Inc. (Attachments: # 1 Exhibit A-H, # 2 Civil Cover Sheet)(twk) (Entered: 02/14/2023) (Main Document) (22) |
| Feb 13, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 02/14/2023) (3) |
| Feb 13, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than December 30, 2022 by Genentech and no earlier than January 5, 2023 by Shionogi & Co., Ltd. Date of Expiration of Patent: U.S. Patent No. 8,927,710 expires on May 5, 2031; U.S. Patent No. 8,987,441 expires on September 21, 2031; U.S. Patent No. 9,815,835 expires on June 14, 2030; U.S. Patent No. 10,392,406 expires on April 27, 2036; U.S. Patent No. 10,633,397 expires on April 27, 2036; U.S. Patent No. 10,759,814 expires on August 9, 2037; U.S. Patent No. 11,261,198 expires on September 25, 2038; and U.S. Patent No. 11,306,106 expires on August 9, 2037. Thirty Month Stay Deadline: 4/24/2026. (twk) (Entered: 02/14/2023) (1) |
| Feb 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,927,710 B2; 8,987,441 B2; 9,815,835 B2; 10,392,406 B2; 10,633,397 B2; 10,759,814 B2; 11,261,198 B2; 11,306,106 B2. (Attachments: # 1 Additional Patents)(twk) (Entered: 02/14/2023) (Main Document) (1) |
| Feb 13, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc., Other Affiliate Roche Holding Ltd. for Genentech, Inc., Hoffmann-La Roche Inc. - filed by Genentech, Inc., Hoffmann-La Roche Inc. (twk) (Entered: 02/14/2023) (2) |
| Feb 13, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (twk) (Entered: 02/14/2023) (1) |
| Feb 13, 2023 | 7 | Summons Issued as to Alvogen PB Research & Development LLC on 2/14/2023; Norwich Pharmaceuticals, Inc. on 2/14/2023. (Attachments: # 1 Summons Issued)(twk) (Entered: 02/14/2023) (Main Document) (2) |
| Feb 13, 2023 | 7 | Summons Issued as to Alvogen PB Research & Development LLC on 2/14/2023; Norwich Pharmaceuticals, Inc. on 2/14/2023. (Attachments: # 1 Summons Issued)(twk) (Entered: 02/14/2023) (Summons Issued) (2) |
| Feb 13, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4066373.) - filed by Shionogi & Co., Ltd., Genentech, Inc., Hoffmann-La Roche Inc. (Attachments: # 1 Exhibit A-H, # 2 Civil Cover Sheet)(twk) (Entered: 02/14/2023) (Exhibit A-H) (30) |
| Feb 13, 2023 | 1 | COMPLAINT FOR PATENT INFRINGEMENT filed against Alvogen PB Research & Development LLC, Norwich Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4066373.) - filed by Shionogi & Co., Ltd., Genentech, Inc., Hoffmann-La Roche Inc. (Attachments: # 1 Exhibit A-H, # 2 Civil Cover Sheet)(twk) (Entered: 02/14/2023) (Civil Cover Sheet) (2) |
| Feb 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,927,710 B2; 8,987,441 B2; 9,815,835 B2; 10,392,406 B2; 10,633,397 B2; 10,759,814 B2; 11,261,198 B2; 11,306,106 B2. (Attachments: # 1 Additional Patents)(twk) (Entered: 02/14/2023) (Additional Patents) (1) |
